ASX:FTTFactor Therapeutics Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Factor Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume425,600 shsAverage Volume433,334 shsMarket Capitalization$4.17 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsHeadlines Factor Therapeutics Limited, a clinical stage biotechnology company, develops treatments for wound care and healing. The company was formerly known as Tissue Therapies Limited and changed its name to Factor Therapeutics Limited in May 2016. Factor Therapeutics Limited is headquartered in Brisbane, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Factor Therapeutics. Previous Next 2.7 Community Rank Outperform VotesFactor Therapeutics has received 84 “outperform” votes. (Add your “outperform” vote.)Underperform VotesFactor Therapeutics has received 73 “underperform” votes. (Add your “underperform” vote.)Community SentimentFactor Therapeutics has received 53.50% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Factor Therapeutics and other stocks. Vote “Outperform” if you believe FTT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FTT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldFactor Therapeutics does not currently pay a dividend.Dividend GrowthFactor Therapeutics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Factor Therapeutics insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Factor Therapeutics is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Factor Therapeutics is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolASX:FTT Previous SymbolASX:TIS CUSIPN/A CIKN/A Webfactor-therapeutics.com Phone+61-7-33343900Debt Debt-to-Equity RatioN/A Current Ratio12.78 Quick Ratio12.45Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.49 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.00 Book ValueA$0.00 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares1,042,840,000Market Cap$4.17 million Next Earnings DateN/A OptionableNot Optionable Receive FTT News and Ratings via Email Sign-up to receive the latest news and ratings for FTT and its competitors with MarketBeat's FREE daily newsletter. Factor Therapeutics (ASX:FTT) Frequently Asked Questions How were Factor Therapeutics' earnings last quarter? Factor Therapeutics Ltd (ASX:FTT) released its earnings results on Thursday, August, 8th. The biotechnology company reported $0.00 earnings per share for the quarter. View Factor Therapeutics' earnings history. Has Factor Therapeutics been receiving favorable news coverage? Media stories about FTT stock have trended negative on Saturday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Factor Therapeutics earned a news impact score of -2.4 on InfoTrie's scale. They also gave headlines about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Factor Therapeutics. Who are some of Factor Therapeutics' key competitors? Some companies that are related to Factor Therapeutics include Inhibitor Therapeutics (INTI), Destiny Pharma (DEST), Agronomics (ANIC), Biocardia (BCDA), CAN-FITE BIOPHA/S (CANF), Can-Fite Biopharma (CANF), Crescita Therapeutics (CTX), Immuron (IMC), Kane Biotech (KNE), Collagen Solutions (COS), Devonian Health Group (GSD), Hvivo (HVO), Realm Therapeutics (RLM), Bioxyne (BXN) and Rhinomed (RNO). View all competitors. Who are Factor Therapeutics' key executives? Factor Therapeutics' management team includes the following people: Dr. Rosalind Wilson MBBS, MBA, ConsultantMs. Melanie Farris, Company Sec. What is Factor Therapeutics' stock symbol? Factor Therapeutics trades on the ASX under the ticker symbol "FTT." How big of a company is Factor Therapeutics? Factor Therapeutics has a market capitalization of $0.00 and generates $2.49 million in revenue each year. What is Factor Therapeutics' official website? The official website for Factor Therapeutics is factor-therapeutics.com. How can I contact Factor Therapeutics? Factor Therapeutics' mailing address is L 19 179 Turbot St, BRISBANE, QLD 4000, Australia. The biotechnology company can be reached via phone at +61-7-33343900. This page was last updated on 7/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
